Diligence memo · auto-generated · as of July 2, 2026
Truepill, Inc.
Truepill, Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Truepill, Inc. operates in Healthtech, based in Hayward, CA, USA; Remote. API-connected healthcare infrastructure.
Sub-sector tags: Consumer Health Services, healthtech.
Capital & rounds (filed)filed
Truepill, Inc. has raised $307M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $142M on 2021-10-14.
Most recent recorded round closed around 2023-08-16.
Valuation (modeled)modeled
Provath models Truepill, Inc. at approximately $843M (range $353M–$1.3B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.70× the median modeled value of Series D+ Healthtech companies in 2022–2024 (17 peers) — value vs value, same stage and era. Within the normal band (70% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 2.9 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round was 2.2× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 99% of Healthtech peers (2138 compared).
Modeled value ranks above 96% of those peers.
Closest niche peers: Monogram Health Holdings, Inc., Lyra Health, Inc., Aledade, Inc., Clarify Health Solutions, Inc., Insightec Ltd.
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.